Is human leukocyte antigen-matched sibling donor transplant always better than haploidentical allograft?

被引:11
作者
Chang, Ying-Jun [1 ,2 ]
Huang, Xiao-Jun [1 ,2 ,3 ]
机构
[1] Peking Univ Peoples Hosp, Beijing, Peoples R China
[2] Peking Univ, Inst Hematol, Beijing Key Lab Hematopoiet Stem Cell Transplanta, Beijing, Peoples R China
[3] Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China
基金
中国国家自然科学基金;
关键词
Human leukocyte antigen-matched sibling donor transplantation; Haploidentical stem cell transplantation; Graft-vs-leukemia effects; STEM-CELL TRANSPLANTATION; ACUTE LYMPHOBLASTIC-LEUKEMIA; VERSUS-HOST-DISEASE; BONE-MARROW-TRANSPLANTATION; MINIMAL RESIDUAL DISEASE; ACUTE MYELOID-LEUKEMIA; POSTTRANSPLANTATION CYCLOPHOSPHAMIDE; EUROPEAN-SOCIETY; HODGKIN LYMPHOMA; WORKING PARTY;
D O I
10.1053/j.seminhematol.2018.07.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Currently, haploidentical donor has been an alternative source of stem cell allografts for patients who have no human leukocyte antigen-matched sibling donor or unrelated donors. A number of studies indicated that treating hematological malignancy patients with haploidentical stem cell transplantation (haplo-SCT) could achieve comparable outcomes to those who underwent matched sibling donor transplantation (MSDT). In recent years, more and more evidence support the notion that haploidentical allografts may have a stronger graft-vs-leukemia (GVL) effect than MSDT. In this review, we summarized the transplant outcomes of haplo-SCT and MSDT, mainly focusing on the subgroup of patients who will benefit from the stronger GVL effects of haplo-SCT compared with MSDT. We also offered strategies of how to translate the strong antileukemia activity of haploidentical allograft into superior survival. Future directions of GVL effects in haplo-SCT settings were also discussed. (C) 2018 Published by Elsevier Inc.
引用
收藏
页码:201 / 208
页数:8
相关论文
共 53 条
[1]   Impact of Donor Type in Patients with AML Given Allogeneic Hematopoietic Cell Transplantation After Low-Dose TBI-Based Regimen [J].
Baron, Frederic ;
Labopin, Myriam ;
Ruggeri, Annalisa ;
Cornelissen, Jan J. ;
Meijer, Ellen ;
Sengeloev, Henrik ;
Niederwieser, Dietger ;
De Groot, Marco R. ;
Schouten, Harry C. ;
Milpied, Noel ;
Blaise, Didier ;
Savani, Bipin N. ;
Gluckman, Eliane ;
Mohty, Mohamad ;
Nagler, Arnon .
CLINICAL CANCER RESEARCH, 2018, 24 (12) :2794-2803
[2]   Mobilized Peripheral Blood Stem Cells Versus Unstimulated Bone Marrow As a Graft Source for T-Cell-Replete Haploidentical Donor Transplantation Using Post-Transplant Cyclophosphamide [J].
Bashey, Asad ;
Zhang, Mei-Jie ;
McCurdy, Shannon R. ;
St Martin, Andrew ;
Argall, Trevor ;
Anasetti, Claudio ;
Ciurea, Stefan O. ;
Fasan, Omotayo ;
Gaballa, Sameh ;
Hamadani, Mehdi ;
Munshi, Pashna ;
Al Malki, Monzr M. ;
Nakamura, Ryotaro ;
O'Donnell, Paul V. ;
Perales, Miguel-Angel ;
Raj, Kavita ;
Romee, Rizwan ;
Rowley, Scott ;
Rocha, Vanderson ;
Salit, Rachel B. ;
Solh, Melhem ;
Soiffer, Robert J. ;
Fuchs, Ephraim Joseph ;
Eapen, Mary .
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (26) :3002-+
[3]   T-Cell-Replete HLA-Haploidentical Hematopoietic Transplantation for Hematologic Malignancies Using Post-Transplantation Cyclophosphamide Results in Outcomes Equivalent to Those of Contemporaneous HLA-Matched Related and Unrelated Donor Transplantation [J].
Bashey, Asad ;
Zhang, Xu ;
Sizemore, Connie A. ;
Manion, Karen ;
Brown, Stacey ;
Holland, H. Kent ;
Morris, Lawrence E. ;
Solomon, Scott R. .
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (10) :1310-1316
[4]   Strategies to Inhibit Alloantibody Production in Alloprimed Murine Recipients of Hematopoietic Stem Cell Grafts [J].
Blazar, B. R. ;
Flynn, R. ;
Lee, R. ;
Marcucci, G. ;
Caliguiri, M. A. ;
Heeger, P. S. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15 (04) :931-941
[5]   Graft-versus-leukemia Effect of HLA-haploidentical Central-memory T-cells Expanded With Leukemic APCs and Modified With a Suicide Gene [J].
Casucci, Monica ;
Perna, Serena Kimi ;
Falcone, Laura ;
Camisa, Barbara ;
Magnani, Zulma ;
Bernardi, Massimo ;
Crotta, Alessandro ;
Tresoldi, Cristina ;
Fleischhauer, Katharina ;
Ponzoni, Maurilio ;
Gregori, Silvia ;
Cappio, Federico Caligaris ;
Ciceri, Fabio ;
Bordignon, Claudio ;
Cignetti, Alessandro ;
Bondanza, Attilio ;
Bonini, Chiara .
MOLECULAR THERAPY, 2013, 21 (02) :466-475
[6]   Effects of pre- and post-transplantation minimal residual disease on outcomes in pediatric patients with acute myeloid leukemia receiving human leukocyte antigen-matched or mismatched related donor allografts [J].
Chang, Ying-Jun ;
Zhao, Xiao-Su ;
Wang, Yu ;
Liu, Yan-Rong ;
Xu, Lan-Ping ;
Zhang, Xiao-Hui ;
Chen, Huan ;
Chen, Yu-Hong ;
Han, Wei ;
Sun, Yu-Qian ;
Yan, Chen-Hua ;
Mo, Xiao-Dong ;
Liu, Kai-Yan ;
Huang, Xiao-Jun .
AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (12) :E659-E661
[7]   Haploidentical allograft is superior to matched sibling donor allograft in eradicating pre-transplantation minimal residual disease of AML patients as determined by multiparameter flow cytometry: a retrospective and prospective analysis [J].
Chang, Ying-Jun ;
Wang, Yu ;
Liu, Yan-Rong ;
Xu, Lan-Ping ;
Zhang, Xiao-Hui ;
Chen, Huan ;
Chen, Yu-Hong ;
Wang, Feng-Rong ;
Han, Wei ;
Sun, Yu-Qian ;
Yan, Chen-Hua ;
Tang, Fei-Fei ;
Mo, Xiao-Dong ;
Liu, Kai-Yan ;
Huang, Xiao-Jun .
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2017, 10
[8]   Controlled, Randomized, Open-Label Trial of Risk-Stratified Corticosteroid Prevention of Acute Graft-Versus-Host Disease After Haploidentical Transplantation [J].
Chang, Ying-Jun ;
Xu, Lan-Ping ;
Wang, Yu ;
Zhang, Xiao-Hui ;
Chen, Huan ;
Chen, Yu-Hong ;
Wang, Feng-Rong ;
Han, Wei ;
Sun, Yu-Qian ;
Yan, Chen-Hua ;
Tang, Fei-Fei ;
Mo, Xiao-Dong ;
Liu, Kai-Yan ;
Huang, Xiao-Jun .
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (16) :1855-+
[9]   How do we choose the best donor for T-cell-replete, HLA-haploidentical transplantation? [J].
Chang, Ying-Jun ;
Luznik, Leo ;
Fuchs, Ephraim J. ;
Huang, Xiao-Jun .
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2016, 9
[10]   Haploidentical stem cell transplantation: anti-thymocyte globulin-based experience [J].
Chang, Ying-Jun ;
Huang, Xiao-Jun .
SEMINARS IN HEMATOLOGY, 2016, 53 (02) :82-89